GRACE :: Treatments & Symptom Management

leukemia

GRACE Video

New Approaches to Immunotherapy

Share

IO_2015_Slingluff_New_Immunotherapy_Approaches

 

Dr. Craig L. Slingluff, University of Virginia, discusses novel approaches to immunotherapy, including adoptive T-cell therapy, personalized cancer vaccines and personalized selection of immune therapies.

[ratingwidget post_id=0]

Please feel free to offer comments and raise questions in our Discussion Forums.


ExecDirCarlea

Join GRACE and Friends at the Cancer Immunotherapy Patient Forum Nov. 7th

Share

Cancer immunotherapy – also called immuno-oncology – uses a cancer patient’s own immune system to kill cancer cells. The number of cancer types that may benefit from immunotherapy is increasing – leading patients to wonder if the treatment is right for them.

GRACE, along with the Melanoma Research Alliance and the Society for Immunotherapy of Cancer, will hold a patient forum Saturday, November 7, 2015 near Washington, DC. Patients and caregivers with melanoma, leukemia/lymphoma, lung, or genitourinary cancers will get the answers they want from leading immunotherapy experts. The event will take place at the Gaylord National Hotel & Convention Center in National Harbor, Maryland.

The topics include:

  • What is Immunotherapy & Its Mechanisms of Action?
  • The Current Role of Immunotherapy
  • Managing Immunotherapy Side Effects
  • Biomarkers and Patient Selection
  • Novel Immunotherapies and Combinations, and
  • New Approaches to Immunotherapy

Additionally, breakouts for melanoma, leukemia/lymphoma, lung and genitourinary cancers will give patients information about their specific conditions.

Registration is $25 per person.

View the agenda for additional details and a list of confirmed faculty.

Thanks to our Advocacy Partners

Aim at Melanoma, Bladder Cancer Action Network, Addario Lung Cancer Foundation, Cancer Support Community, Free to Breathe, Lung Cancer Alliance, LUNGevity, Melanoma International Foundation, and the Mollie Biggane Melanoma Fund.

The Immunotherapy Patient Forum is supported in part by grants from Amgen, Bristol-Myers Squibb, Genentech, and Merck & Co., Inc.

 

 


Ask Us, Q&A
Cancer Treatments / Symptom Management Expert Content

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243